Associate Professor of Internal Medicine
[email protected]
Available to mentor
Peter M Farrehi
Clinical Associate Professor
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
-
Effron MB, Sleem A, Stebbins A, Wruck LM, Gravel G, Muñoz D, Re RN, gupta K, Pepine C, Jain S, Girotra S, Whittle J, Benziger C, Farrehi PM, Knowlton KU, Polonsky TS, Roe MT, Rothman RT, Harrington RA, Jones WS, Hernandez AF. Circulation, 2022 Nov 8; 146 (Suppl_1): a14286 - a14286.Journal ArticleAbstract 14286: Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial
DOI:10.1161/circ.146.suppl_1.14286 -
Jamnadas J, Acho M, Farrehi P. SLEEP, 2022 45: A367 - A367.Proceeding / Abstract / PosterA CASE OF COMPLETE HEART BLOCK IN A PATIENT WITH SEVERE OBSTRUCTIVE SLEEP APNEA
-
Effron MB, Sleem A, Stebbins A, Wruck LM, Gravel G, Munoz D, Re RN, Gupta K, Pepine C, Jain S, Girotra S, Whittle J, Benziger C, Farrehi PM, Knowlton KU, Polonsky TS, Roe MT, Rothman RT, Harrington RA, Jones WS, Hernandez AF. CIRCULATION, 2022 146:Proceeding / Abstract / PosterComparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial
-
Girotra S, Stebbins A, Wruck LM, Riley D, Kripalani S, Munoz D, Effron MB, Gupta K, Whittle J, Benziger C, Zhou L, Farrehi PM, Polonsky TS, Ahmad FS, Roe MT, Rothman R, Harrington RA, Hernandez AF, Jones WS. CIRCULATION, 2022 146:Proceeding / Abstract / PosterEffect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events
-
Marquis-Gravel G, Stebbins A, Wruck LM, Roe MT, Effron MB, Hammill BG, Whittle J, VanWormer JJ, Robertson HR, Alikhaani JD, Kripalani S, Farrehi PM, Girotra S, Benziger CP, Polonsky TS, Merritt JG, Gupta K, McCormick TE, Knowlton KU, Jain SK, Kochar A, Rothman RL, Harrington RA, Hernandez AF, Jones WS. J Am Heart Assoc, 2024 Feb 20; 13 (4): e026921Journal ArticleAge and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
DOI:10.1161/JAHA.122.026921 PMID: 38348779 -
Narcisse DI, Kim H, Wruck LM, Stebbins AL, Muñoz D, Kripalani S, Effron MB, Gupta K, Anderson RD, Jain SK, Girotra S, Whittle J, Benziger CP, Farrehi P, Zhou L, Polonsky TS, Ahmad FS, Roe MT, Rothman RL, Harrington RA, Hernandez AF, Jones WS. Diabetes Care, 2024 Jan 1; 47 (1): 81 - 88.Journal ArticleComparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial.
DOI:10.2337/dc23-0749 PMID: 37713477 -
Sleem A, Effron MB, Stebbins A, Wruck LM, Marquis-Gravel G, Muñoz D, Re RN, Gupta K, Pepine CJ, Jain SK, Girotra S, Whittle J, Benziger CP, Farrehi PM, Knowlton KU, Polonsky TS, Roe MT, Rothman RL, Harrington RA, Jones WS, Hernandez AF. JAMA Cardiol, 2023 Nov 1; 8 (11): 1061 - 1069.Journal ArticleEffectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
DOI:10.1001/jamacardio.2023.3364 PMID: 37792369 -
Girotra S, Stebbins A, Wruck L, Marquis-Gravel G, Gupta K, Farrehi P, Benziger CP, Effron MB, Whittle J, Muñoz D, Kripalani S, Anderson RD, Jain SK, Polonsky TS, Ahmad FS, Roe MT, Rothman RL, Harrington RA, Hernandez AF, Jones WS. J Am Heart Assoc, 2023 Oct 17; 12 (20): e030385Journal ArticleAspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors.
DOI:10.1161/JAHA.123.030385 PMID: 37830344